Atalanta Sosnoff Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Atalanta Sosnoff Capital's ELV Position: Q1 2024 in Review
Atalanta Sosnoff Capital sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 103,606 shares — an estimated $48.9M sold.
Atalanta Sosnoff Capital first reported a position in ELV in Q3 2015 and held it in 14 quarters. The position peaked at $121M in Q2 2022. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.
- Atalanta Sosnoff Capital reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
- Atalanta Sosnoff Capital sold 103,606 Elevance Health shares in Q1 2024, an estimated $48.9M.
- Atalanta Sosnoff Capital first reported a position in Elevance Health in Q3 2015 and held it in 14 quarters.
- Atalanta Sosnoff Capital's Elevance Health position peaked at $121M in Q2 2022.
- 1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.
Based on Atalanta Sosnoff Capital's 13F filing for Q1 2024, filed 14 May 2024.